iron in iron-deficient CHF patients on renal function, and the efficacy and safety of this therapy in patients with renal dysfunction.Methods and resultsThe FAIR-HF trial randomized 459 CHF patients with iron deficiency (ferritin 0.20 for interactions). No interaction between the favourable effects ...
摘要: Publication » PCV65 HEALTH ECONOMIC ASSESSMENT OF FERRIC CARBOXYMALTOSE IN PATIENTS WITH IRON DEFICIENCY AND CHRONIC HEART FAILURE IN THE FAIR-HF TRIAL.DOI: 10.1016/S1098-3015(11)72408-1 被引量: 41 年份: 2010 收藏 引用 批量引用 报错 分享 全部来源 免费下载 求助全文 Elsevier (...
Red cell distribution width (RDW), a measure of variability in red blood cell size, is a novel prognostic marker in chronic heart failure (CHF). Iron deficiency contributes to elevated RDW. In the FAIR-HF trial, i.v. ferric carboxymaltose (FCM) improved the 6 min walk test (6MWT) dista...
HeartMate II continuous-flow VAD sets new benchmark in destination-therapy trial FAIR-HF: Symptom improvement, functional gains follow correction of iron deficiency in heart failure HEAAL: High-dose trumps low-dose ARB for heart failure in the ACE-inhibitor intolerant CASCADE: No significant be...
Fuel Cell Bus Trial, Perth, Australia California Hydrogen Highway, USA SPACEFEST 2009, San Diego, USA Impressions from worldwide Conferences, which we attended to promote the commercialisation of Hydrogen and Fuel Cells: 2022 #117 2nd Edition of International Conference on Green Chemistry and...
Fuel Cell Bus Trial, Perth, Australia California Hydrogen Highway, USA SPACEFEST 2009, San Diego, USA Impressions from worldwide Conferences, which we attended to promote the commercialisation of Hydrogen and Fuel Cells: 2022 #1172nd Edition of International ...
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial Therapy with i.v. iron in patients with chronic heart failure (CHF) and iron deficiency (ID) improves symptoms, functional capacity, and quality of life...
The approved draft of Standards Relating to Fair Trial and Free Press, generally referred to as the Reardon Report, is the organized bar's response to the ... MD Deitchler,HF Hahn 被引量: 0发表: 1969年 Problems in Defining the Institutional Status of the Press Specifically, the focus will...
1、Liu XY, Hu JH, Wang HF. Analysis of prognostic factors for patients with acute-on-chronic liver failure. Chin J Hepatol. 2009;17:607–610. 2、Ringelhan M, Pfister D, O'Connor T, Pikarsky E, Heikenwalder M. The immunology of hepatocellular carcinoma. Nat Immunol. 2018 Mar;19(3)...
Jose Gonzalez-Costello,Josep Comin-Colet.Iron deficiency and anaemia in heart failure: understanding the FAIR-HF trial.EUROPEAN JOURNAL OF HEART FAILURE. 2010J. Gonza´lez-Costello and J. Com´in-Colet, "Iron deficiency and anaemia in heart failure: understanding the FAIR-HF trial," European...